OBJECTIVE: The objective of the study was to evaluate the psychometric properties of the Sexual Health Outcomes in Women Questionnaire (SHOW-Q). STUDY DESIGN: SHOW-Q was developed to assess the impact of pelvic problems on sexual desire, frequency, satisfaction, orgasm, and discomfort. A total of 1833 English- or Spanish-speaking women enrolled in 5 studies across the United States completed relevant items at baseline and, for 4 studies, periodically thereafter. Participants also completed measures of pelvic symptomatology and health-related quality-of-life including mental and physical component scales (MCS, PCS). RESULTS: Factor analysis revealed a 12-item scale with high internal consistency reliability (Cronbach's alpha = 0.86) and 4 reliable subscales (alpha = 0.73 to 0.84). Among sexually active women, SHOW-Q scores showed statistically significant correlations (P < .001) with MCS (0.267), PCS (0.378), body image (.360), and symptom resolution (.237). The SHOW-Q subscales were also correlated with these other measures at baseline and over time. CONCLUSION: SHOW-Q is a reliable, valid, and sensitive measure of sexual functioning for use in diverse women's health outcome studies.
OBJECTIVE: The objective of the study was to evaluate the psychometric properties of the Sexual Health Outcomes in Women Questionnaire (SHOW-Q). STUDY DESIGN: SHOW-Q was developed to assess the impact of pelvic problems on sexual desire, frequency, satisfaction, orgasm, and discomfort. A total of 1833 English- or Spanish-speaking women enrolled in 5 studies across the United States completed relevant items at baseline and, for 4 studies, periodically thereafter. Participants also completed measures of pelvic symptomatology and health-related quality-of-life including mental and physical component scales (MCS, PCS). RESULTS: Factor analysis revealed a 12-item scale with high internal consistency reliability (Cronbach's alpha = 0.86) and 4 reliable subscales (alpha = 0.73 to 0.84). Among sexually active women, SHOW-Q scores showed statistically significant correlations (P < .001) with MCS (0.267), PCS (0.378), body image (.360), and symptom resolution (.237). The SHOW-Q subscales were also correlated with these other measures at baseline and over time. CONCLUSION: SHOW-Q is a reliable, valid, and sensitive measure of sexual functioning for use in diverse women's health outcome studies.
Authors: W Jerod Greer; Holly E Richter; Thomas L Wheeler; R Edward Varner; Jeff M Szychowski; Miriam Kuppermann; Lee A Learman Journal: Female Pelvic Med Reconstr Surg Date: 2010-01 Impact factor: 2.091
Authors: Alison J Huang; Tami S Rowen; Priscilla Abercrombie; Leslee L Subak; Michael Schembri; Traci Plaut; Maria T Chao Journal: Pain Med Date: 2017-10-01 Impact factor: 3.750
Authors: Janet S Carpenter; Susan D Reed; Katherine A Guthrie; Joseph C Larson; Katherine M Newton; R Jane Lau; Lee A Learman; Jan L Shifren Journal: Sex Med Date: 2015-03 Impact factor: 2.523
Authors: Luigi Della Corte; Claudia Di Filippo; Olimpia Gabrielli; Sabrina Reppuccia; Valentina Lucia La Rosa; Rosalia Ragusa; Michele Fichera; Elena Commodari; Giuseppe Bifulco; Pierluigi Giampaolino Journal: Int J Environ Res Public Health Date: 2020-06-29 Impact factor: 3.390
Authors: Gordon Forbes; Sian Newton; Clara Cantalapiedra Calvete; Judy Birch; Julie Dodds; Liz Steed; Carol Rivas; Khalid Khan; Frank Röhricht; Stephanie Taylor; Brennan C Kahan; Elizabeth Ball Journal: BMJ Open Date: 2020-03-12 Impact factor: 2.692
Authors: Elizabeth Ball; Sian Newton; Brennan C Kahan; Gordon Forbes; Neil Wright; Clara Cantalapiedra Calvete; Harry A L Gibson; Ewelina Rogozinska; Carol Rivas; Stephanie J C Taylor; Judy Birch; Julie Dodds Journal: JMIR Res Protoc Date: 2018-01-15